About Epsilen Bio
Epsilen Bio is a company based in Milano (Italy) founded in 2019 by Angelo Lombardo and Luigi Naldini was acquired by Chroma Medicine in November 2021.. Epsilen Bio offers products and services including Epigenetic Silencing. Epsilen Bio operates in a competitive market with competitors including Chroma Medicine, Bluepha, FOXO Technologies, Reaction Biology and Chronomics, among others.
- Headquarter Milano, Italy
- Founders Angelo Lombardo, Luigi Naldini
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
Chroma Medicine
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Chroma Medicine
(Nov 17, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Epsilen Bio
Epsilen Bio offers a comprehensive portfolio of products and services, including Epigenetic Silencing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Method to treat human diseases via epigenetic techniques.
Unlock access to complete
Unlock access to complete
Funding Insights of Epsilen Bio
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2020 | Amount | Seed - Epsilen Bio | Valuation | Sofinnova Partners |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Epsilen Bio
Epsilen Bio has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Chroma Medicine and Sofinnova Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sofinnova Partners is focused on life sciences and healthcare investments.
|
Founded Year | Domain | Location | |
|
Epigenetic editing platform is developed for genomic medicines.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Epsilen Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Epsilen Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Epsilen Bio Comparisons
Competitors of Epsilen Bio
Epsilen Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Chroma Medicine, Bluepha, FOXO Technologies, Reaction Biology and Chronomics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Epigenetic editing platform is developed for genomic medicines.
|
|
| domain | founded_year | HQ Location |
Microbial manufacturing for bio-based products is developed.
|
|
| domain | founded_year | HQ Location |
Epigenetic biomarkers are discovered and developed via AI platforms.
|
|
| domain | founded_year | HQ Location |
In vitro enzyme activity assays, secializing in kinase & epigenetic HTS and profiling
|
|
| domain | founded_year | HQ Location |
Proactive healthcare analysis is enabled by DNA-based epigenetic tests.
|
|
| domain | founded_year | HQ Location |
Biomedical company offering DNA/RNA purification kits and NGS services for research.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Epsilen Bio
Frequently Asked Questions about Epsilen Bio
When was Epsilen Bio founded?
Epsilen Bio was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Where is Epsilen Bio located?
Epsilen Bio is headquartered in Milano, Italy.
Who is the current CEO of Epsilen Bio?
Julia Berretta is the current CEO of Epsilen Bio.
What does Epsilen Bio do?
Founded in 2019 in Milano, Italy, Epsilen Bio operates in the biotechnology sector, where therapies are developed using Epigenetic Transcriptional Repressors (ETRs) for gene silencing. These approaches target inherited genetic diseases, cancer, autoimmune conditions, degenerative disorders, and viral infections. Operations focus on advancing clinical applications through innovative epigenetic mechanisms, with leadership provided by co-founders Angelo Lombardo and Luigi Naldini, alongside CEO Julia Berretta.
Who are the top competitors of Epsilen Bio?
Epsilen Bio's top competitors include Chroma Medicine, FOXO Technologies and Bluepha.
What products or services does Epsilen Bio offer?
Epsilen Bio offers Epigenetic Silencing.
Who are Epsilen Bio's investors?
Epsilen Bio has 2 investors. Key investors include Chroma Medicine, and Sofinnova Partners.